Charles Schwab Investment Management Inc. Buys 4,082 Shares of Axcelis Technologies, Inc. $ACLS

Charles Schwab Investment Management Inc. boosted its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 431,195 shares of the semiconductor company’s stock after purchasing an additional 4,082 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Axcelis Technologies were worth $34,642,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. REAP Financial Group LLC bought a new stake in Axcelis Technologies during the fourth quarter valued at about $25,000. Close Asset Management Ltd bought a new stake in Axcelis Technologies during the third quarter valued at about $27,000. EverSource Wealth Advisors LLC boosted its position in Axcelis Technologies by 145.1% during the second quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after purchasing an additional 267 shares in the last quarter. Caitlin John LLC bought a new stake in Axcelis Technologies during the third quarter valued at about $32,000. Finally, Advisory Services Network LLC bought a new stake in Axcelis Technologies during the third quarter valued at about $32,000. Institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Trading Down 4.0%

Shares of NASDAQ:ACLS opened at $155.18 on Friday. Axcelis Technologies, Inc. has a 52-week low of $55.93 and a 52-week high of $171.61. The stock has a market cap of $4.77 billion, a price-to-earnings ratio of 48.34, a PEG ratio of 12.35 and a beta of 1.93. The company has a quick ratio of 2.99, a current ratio of 4.59 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average price of $114.63 and a 200-day moving average price of $95.94.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. Axcelis Technologies had a return on equity of 12.19% and a net margin of 11.93%.The firm had revenue of $198.96 million during the quarter, compared to analysts’ expectations of $195.03 million. During the same period last year, the business posted $0.88 earnings per share. The company’s revenue for the quarter was up 3.3% compared to the same quarter last year. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Equities analysts predict that Axcelis Technologies, Inc. will post 2.86 EPS for the current year.

Analysts Set New Price Targets

ACLS has been the topic of a number of recent research reports. B. Riley Financial raised Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price objective on the stock in a research report on Monday, April 20th. Zacks Research raised Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, Weiss Ratings downgraded Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $116.25.

Insider Transactions at Axcelis Technologies

In other news, CEO Russell Low sold 7,468 shares of the firm’s stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $156.75, for a total value of $1,170,609.00. Following the completion of the transaction, the chief executive officer directly owned 123,570 shares in the company, valued at $19,369,597.50. This trade represents a 5.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jorge Titinger sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $164.14, for a total value of $328,280.00. Following the completion of the transaction, the director owned 4,477 shares of the company’s stock, valued at approximately $734,854.78. The trade was a 30.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 21,686 shares of company stock valued at $3,282,508. 0.49% of the stock is owned by company insiders.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.